Grasp-Release Assessment of a Networked Neuroprosthesis Device
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorMetroHealth Medical Center
About this trial
The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.
Eligibility criteria
Qualifiers
Male or female, age > 16 years.
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) motor level of C1 through C7 and
American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A, B, or C;
Six months or more post-injury (neurostability);
Disqualifiers
Other neurological conditions (MS(multiple Sclerosis), diabetes with peripheral nerve involvement); Associated peripheral nerve / brachial plexus injury
Progressive SCI;
Co-existing cervical spine pathology (syrinx, unstable segment)
Active implantable medical device (AIMD) such as a pacemaker or defibrillator;
Trial design
Treatments tested in this trial
- Networked Neuroprosthesis Device
Treatment groups
13 Participants
are divided into 1 treatment groupSponsors and collaborators
MetroHealth Medical Center
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Case Western Reserve University
Collaborator
Source ClinicalTrials.gov